MODERN APPROACHES TO THE MANAGEMENT OF PRETERM LABOR: PREVENTION, DIAGNOSIS, TREATMENT STRATEGIES
Keywords:
Preterm labor, prevention, diagnosis, treatment, tocolytics.Abstract
It is commonly acknowledged that one of the main causes of neonatal morbidity and mortality is preterm labor. In our paper, we examined the relative effectiveness of atosiban and nifedipine in treating preterm labor threats. We knew from earlier studies that both drugs are frequently used as tocolytics, but there is still debate regarding their relative efficacy. Three tertiary care facilities and 240 pregnant women between the ages of 24 and 34 participated in our randomized controlled trial. In a double-blind procedure, participants were randomized to receive atosiban or nifedipine. We evaluated a number of outcomes, such as maternal safety, neonatal condition, gestational age at delivery, and latency period. According to our research, nifedipine considerably extended the latency period when compared to atosiban (p<0.01). Nifedipine was associated with better neonatal outcomes, even though both drugs showed similar maternal safety profiles. Our findings suggest that nifedipine may be more advantageous when treating preterm labor threats.
References
Ng, V. W. Y., Seto, M., Lewis, H., et al. (2023). A prospective, double-blinded cohort study using quantitative fetal fibronectin testing in symptomatic women for the prediction of spontaneous preterm delivery. BMC Pregnancy and Childbirth, 23, 225. https://doi.org/10.1186/s12884-023-05543-3
Peng, Y., Gao, Z., Yuan, X., & Kuang, Y. (2024). Effects of vaginal progesterone and placebo on preterm birth and antenatal outcomes in women with singleton pregnancies and short cervix on ultrasound: A meta-analysis. BMC Pregnancy and Childbirth, 24, 318. https://pubmed.ncbi.nlm.nih.gov/38646553/
Zamani, M., Alimi, R., Arabi, S. M., et al. (2024). Comparison of the efficacy of nifedipine with ritodrine, nitroglycerine and magnesium sulfate for the management of preterm labor: A systematic review and meta-analysis. BMC Pregnancy and Childbirth, 24, 318. https://doi.org/10.1186/s12884-024-06497-w
Eshraghi, S., et al. (2025). Combined use of vaginal progesterone and cervical pessary vs progesterone monotherapy to prevent preterm birth in women with short cervix. BMC Pregnancy and Childbirth, 25, 1055. https://bmcpregnancychildbirth.biomedcentral.com/counter/pdf/10.1186/s12884-025-08255-y.pdf
Kurt, A., Ulusoy, C. O., Kurt, D. S., et al. (2025). Impact of antenatal corticosteroid therapy on neonatal respiratory outcomes in late preterm births. BMC Pediatrics, 25, 59. https://bmcpediatr.biomedcentral.com/articles/10.1186/s12887-025-05925-w
Plouchart, T., et al. (2024). Tocolysis and neurodevelopment of children born very preterm. JAMA Network Open, 7(3), e2825510. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2825510
Updated meta-analysis (2025). Vaginal progesterone reduces the risk of preterm birth and adverse perinatal outcomes in singleton gestations with a midtrimester short cervix (≤ 25 mm): An updated individual patient data meta-analysis. Obstetrics & Gynecology Project. https://www.obgproject.com/2025/07/13/updated-meta-analysis-vaginal-progesterone-reduces-the-risk-of-preterm-birth